Bangladesh inks MoU with Indian company for COVID-19 vaccine

The Bangladesh government has signed a Memorandum of Understanding (MoU) with Serum Institute of India Pvt Limited and Beximco Pharmaceuticals Ltd (BPL) to get 30 million dodges of SARS-Cov-2 AZD 1222 (Oxford/Astrazeneca Vaccine)

Nov 05, 2020
Image
a

The Bangladesh government has signed a Memorandum of Understanding (MoU) with Serum Institute of India Pvt Limited and Beximco Pharmaceuticals Ltd (BPL) to get 30 million dodges of SARS-Cov-2 AZD 1222 (Oxford/Astrazeneca Vaccine).
 
Additional Secretary to the Health Service Division Mostafa Kamal and representatives from Serum Institute and Beximco Pharmaceuticals Limited of Bangladesh signed the MoU at the Health Ministry in presence of Health Minister Zahid Maleque in Dhaka on Thursday.

As per the MoU, Serum institute will provide SARS-Cov-2 AZD 1222 (Oxford/Astrazeneca Vaccine) to Beximco Pharmaceuticals Ltd (BPL).

https://www.dhakatribune.com/health/coronavirus/2020/11/05/govt-inks-mou-to-get-30-million-covid-19-vaccines

Post a Comment

The content of this field is kept private and will not be shown publicly.